Division of Gastroenterology-Hepatology, Department of Internal Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, Netherlands.
Department of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, Netherlands.
Front Cell Infect Microbiol. 2021 Jul 20;11:639667. doi: 10.3389/fcimb.2021.639667. eCollection 2021.
Stool consistency has been associated with fecal microbial composition. Stool consistency often varies over time, in subjects with and without gastrointestinal disorders, raising the question whether variability in the microbial composition should be considered in microbiota studies. We evaluated within-subject day-to-day variability in stool consistency and the association with the fecal microbiota in irritable bowel syndrome (IBS) and healthy subjects, over seven days.
Twelve IBS patients and 12 healthy subjects collected fecal samples during seven consecutive days. Stool consistency was determined by the patient-reported Bristol Stool Scale (BSS) and fecal dry weight percentage. 16S rRNA V4 gene sequencing was performed and microbial richness (alpha diversity; Chao1 index, observed number of species, effective Shannon index) and microbial community structure (beta diversity; Bray-Curtis distance, generalized UniFrac, and taxa abundance on family level) were determined.
Linear mixed-effects models showed significant associations between stool consistency and microbial richness, but no time effect. This implies that between-subject but not within-subject variation in microbiota over time can partially be explained by variation in stool consistency. Redundancy analysis showed a significant association between stool consistency and microbial community structure, but additional linear mixed-effects models did not demonstrate a time effect on this.
This study supports an association between stool consistency and fecal microbiota, but no effect of day-to-day fluctuations in stool consistency within seven days. This consolidates the importance of considering stool consistency in gut microbiota research, though confirms the validity of single fecal sampling to represent an individual's microbiota at a given time point. NCT00775060.
粪便稠度与粪便微生物组成有关。在有或没有胃肠道疾病的受试者中,粪便稠度通常随时间而变化,这就提出了一个问题,即微生物组成的可变性是否应该在微生物组研究中考虑。我们评估了肠易激综合征(IBS)和健康受试者在七天内粪便稠度的个体内日常变化及其与粪便微生物群的关联。
12 例 IBS 患者和 12 例健康受试者连续七天收集粪便样本。粪便稠度由患者报告的布里斯托粪便量表(BSS)和粪便干重百分比确定。进行 16S rRNA V4 基因测序,并确定微生物丰富度(alpha 多样性;Chao1 指数、观察到的物种数量、有效 Shannon 指数)和微生物群落结构(beta 多样性;Bray-Curtis 距离、广义 UniFrac 和分类群丰度的家庭水平)。
线性混合效应模型显示粪便稠度与微生物丰富度之间存在显著关联,但不存在时间效应。这意味着,随着时间的推移,微生物群在个体内的变化,而不是个体间的变化,部分可以用粪便稠度的变化来解释。冗余分析显示粪便稠度与微生物群落结构之间存在显著关联,但额外的线性混合效应模型并未显示出时间对其的影响。
本研究支持粪便稠度与粪便微生物群之间的关联,但在七天内粪便稠度的日常波动没有影响。这证实了在肠道微生物组研究中考虑粪便稠度的重要性,但也证实了单次粪便取样在给定时间点代表个体微生物组的有效性。NCT00775060。